Variant report

Variant	nsv428611
Chromosome Location	chr13:85975283-86138633
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:11)
LncRNA
region (count:11)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr13:86096125..86097964-chr13:86110495..86113341,2	MCF-7	breast:
2	chr13:86099181..86102107-chr13:86106453..86108708,2	MCF-7	breast:
3	chr13:86012041..86014222-chr13:86015485..86017247,2	K562	blood:
4	chr13:86033358..86036212-chr13:86039864..86042849,2	MCF-7	breast:
5	chr13:86078290..86080136-chr13:86083159..86084884,2	MCF-7	breast:
6	chr13:86078290..86080136-chr13:86083159..86084884,2	MCF-7	breast:
7	chr13:86081905..86084326-chr13:86372446..86374070,2	MCF-7	breast:
8	chr13:86096125..86097964-chr13:86110495..86113341,2	MCF-7	breast:
9	chr13:86033358..86036212-chr13:86039864..86042849,2	MCF-7	breast:
10	chr13:86012041..86014222-chr13:86015485..86017247,2	K562	blood:
11	chr13:86099181..86102107-chr13:86106453..86108708,2	MCF-7	breast:

(count:11 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLITRK5-11	chr13:86107209-86107338	XLOC_010460
2	lnc-SLITRK5-11	chr13:86107211-86107338	ENSG00000226317.2
3	lnc-SLITRK5-11	chr13:85985736-85986331	XLOC_010460
4	lnc-SLITRK5-11	chr13:86116373-86116465	XLOC_010460
5	lnc-SLITRK5-11	chr13:86118511-86118705	XLOC_010460
6	lnc-SLITRK5-11	chr13:86118511-86118797	NONHSAT034564
7	lnc-SLITRK5-11	chr13:86116373-86116465	NONHSAT034564
8	lnc-SLITRK5-11	chr13:86118511-86118705	ENSG00000226317.2
9	lnc-SLITRK5-11	chr13:85982740-85982882	XLOC_010460
10	lnc-SLITRK5-11	chr13:86107211-86107338	NONHSAT034564
11	lnc-SLITRK5-11	chr13:86116373-86116465	ENSG00000226317.2

No data

Variant related genes	Relation type
ENSG00000184564	chromatin interactions
PDE4D	miRNA target sites
PDE3B	miRNA target sites

Extended variants
information (count: 3552 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:3552 , 50 per page) page: 1 2 3 4 5 6 7 ... 72

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs115659301	chr13:85975291-85975292	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs144051541	chr13:85975298-85975299	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs534679090	chr13:85975308-85975309	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs547450956	chr13:85975315-85975316	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs377498553	chr13:85975373-85975374	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs182310740	chr13:85979213-85979214	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs371422307	chr13:85979340-85979341	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs187679605	chr13:85979377-85979378	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs190958196	chr13:85979393-85979394	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs183258474	chr13:85979395-85979396	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs544852848	chr13:85979441-85979442	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs563063593	chr13:85979448-85979449	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs530188339	chr13:85979480-85979481	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs36067299	chr13:85979521-85979522	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs577038778	chr13:85979529-85979530	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs188676351	chr13:85979530-85979531	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs555647397	chr13:85979627-85979628	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs111867070	chr13:85979667-85979668	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs76225828	chr13:85979711-85979712	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs528113165	chr13:85979713-85979714	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs546258523	chr13:85979738-85979739	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs574032408	chr13:85979777-85979778	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs192997392	chr13:85979787-85979788	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs184856023	chr13:85979790-85979791	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs568711013	chr13:85979809-85979810	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs536017358	chr13:85979825-85979826	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs556366772	chr13:85979827-85979828	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs554862978	chr13:85979861-85979862	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs566625232	chr13:85979871-85979872	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs9547203	chr13:85979922-85979923	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs142023680	chr13:85979935-85979936	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs188122752	chr13:85979951-85979952	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs144207678	chr13:85979992-85979993	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs559723732	chr13:85979997-85979998	Weak transcription Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs544714374	chr13:85980000-85980001	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs191351647	chr13:85980084-85980085	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs117374041	chr13:85980114-85980115	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs147768465	chr13:85980127-85980128	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs377398986	chr13:85980138-85980139	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs560869675	chr13:85980158-85980159	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs537956990	chr13:85980166-85980167	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs142660920	chr13:85980194-85980195	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs183881170	chr13:85980195-85980196	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs201229610	chr13:85980207-85980208	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs71125707	chr13:85980208-85980209	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs147922932	chr13:85980209-85980210	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs564538941	chr13:85980218-85980219	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs113814592	chr13:85980234-85980235	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs189320859	chr13:85980332-85980333	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs562207372	chr13:85980340-85980341	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	18632612	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Basal cell lymphoma	17053054	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Breast cancer	21858162	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
abnormal development	18461090	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	21965145	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Urothelial cell carcinoma	18451213	CNVD
Developmental delay	19490664	CNVD
Neurodevelopmental disorder	22521361	CNVD
Cancer	21220470	CNVD
Cancer	21183584	CNVD
Omodysplasia	19481194	CNVD
Breast cancer	22032731	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Cancer	17160897	CNVD
Mantle cell lymphoma	19690137	CNVD
Rhabdomyosarcoma	17210683	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Non-small cell lung cancer	16651412	CNVD
Bipolar disorder	19114987	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:333 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:85974400-85975400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr13:85979200-85979400	Enhancers	Brain Hippocampus Middle	brain
3	chr13:85979400-85979600	Enhancers	Brain Inferior Temporal Lobe	brain
4	chr13:85979400-85979600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
5	chr13:85979400-85979800	Flanking Active TSS	Brain Hippocampus Middle	brain
6	chr13:85979600-85979800	Enhancers	Brain Angular Gyrus	brain
7	chr13:85979600-85980000	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
8	chr13:85979600-85980200	Active TSS	Brain Cingulate Gyrus	brain
9	chr13:85979600-85980800	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
10	chr13:85979600-85981200	Active TSS	Brain Anterior Caudate	brain
11	chr13:85979800-85980400	Weak transcription	Brain Angular Gyrus	brain
12	chr13:85979800-85980400	Active TSS	Brain Hippocampus Middle	brain
13	chr13:85979800-85980400	Enhancers	Brain Substantia Nigra	brain
14	chr13:85980000-85980600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
15	chr13:85980000-85980600	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
16	chr13:85980200-85980800	Flanking Active TSS	Brain Cingulate Gyrus	brain
17	chr13:85980400-85980800	Active TSS	Brain Angular Gyrus	brain
18	chr13:85980400-85980800	Flanking Active TSS	Brain Hippocampus Middle	brain
19	chr13:85980400-85980800	Flanking Active TSS	Brain Substantia Nigra	brain
20	chr13:85980400-85981200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
21	chr13:85980800-85981200	Active TSS	Brain Cingulate Gyrus	brain
22	chr13:85980800-85981200	Active TSS	Brain Hippocampus Middle	brain
23	chr13:85980800-85981200	Active TSS	Brain Inferior Temporal Lobe	brain
24	chr13:85980800-85981200	Active TSS	Brain Substantia Nigra	brain
25	chr13:85981200-85982200	Weak transcription	Brain Substantia Nigra	brain
26	chr13:85982200-85982400	Enhancers	Brain Substantia Nigra	brain
27	chr13:85985800-85986200	Enhancers	Fetal Lung	lung
28	chr13:85985800-85986200	Enhancers	Fetal Stomach	stomach
29	chr13:85986200-86001400	Weak transcription	Fetal Lung	lung
30	chr13:85993600-85994000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr13:85993600-85994000	Enhancers	HMEC	breast
32	chr13:85993600-85994000	Enhancers	NHEK	skin
33	chr13:86001200-86001600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr13:86001400-86001800	Enhancers	Fetal Lung	lung
35	chr13:86002200-86004600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr13:86004800-86005000	ZNF genes & repeats	ES-UCSF4 Cell Line	embryonic stem cell
37	chr13:86005000-86005200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr13:86005200-86005400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
39	chr13:86005200-86005600	ZNF genes & repeats	Foreskin Melanocyte Primary Cells skin01	Skin
40	chr13:86005400-86006200	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
41	chr13:86006000-86006200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr13:86014000-86014200	Enhancers	A549	lung
43	chr13:86014200-86015000	Weak transcription	A549	lung
44	chr13:86015000-86015200	Enhancers	A549	lung
45	chr13:86015200-86016200	Active TSS	A549	lung
46	chr13:86022800-86024400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
47	chr13:86023000-86024600	Enhancers	HUES48 Cell Line	embryonic stem cell
48	chr13:86023200-86023800	Enhancers	iPS-18 Cell Line	embryonic stem cell
49	chr13:86023200-86024200	Enhancers	HUES64 Cell Line	embryonic stem cell
50	chr13:86023400-86023600	Enhancers	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links